Validant Acquires Clinical Outcomes Solutions
May 20, 2021
Validant has acquired Clinical Outcomes Solutions (COS), a UK‑headquartered specialist in clinical outcomes assessment (COA) and HEOR services with US offices in Tucson and Chicago. The acquisition expands Validant’s life‑sciences consulting capabilities by adding COS’s patient‑centered COA expertise to its global regulatory and quality services.
- Buyers
- Validant
- Targets
- Clinical Outcomes Solutions
- Industry
- Healthcare Services
- Location
- United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Lumanity Acquires Endpoint Outcomes
June 14, 2022
Healthcare Services
Lumanity has acquired Endpoint Outcomes, a specialist in patient-centered clinical outcomes assessments, to strengthen and broaden its health economics and outcomes research (HEOR) capabilities. The acquisition integrates Endpoint's COA expertise with Lumanity's existing HEOR, medical, commercial, and regulatory capabilities to create a comprehensive global HEOR service offering.
-
Validant (GHO-backed) Acquires Oriel STAT A MATRIX
April 15, 2021
Healthcare Services
Validant, a transatlantic quality, compliance and regulatory consulting group and portfolio company of GHO Capital, has acquired Oriel STAT A MATRIX, a New Jersey–headquartered consultancy and training firm serving the medical device, IVD and combination product markets. The deal expands Validant’s capabilities into training services and deepens its regulatory consulting bench as part of an international add-on growth strategy.
-
Verana Health Acquires COTA Healthcare
January 9, 2026
Data & Analytics
Verana Health has acquired oncology-focused COTA (COTA Healthcare) in a transaction supported by a $52 million equity commitment from existing backers. The merger expands Verana's real-world data and analytics capabilities into oncology and gives the combined firm access to more than 95 million patients and over 20,000 contributing clinicians, broadening its offering to biopharma customers across clinical trials and outcomes research.
-
Validant Acquires DataRevive
November 1, 2019
Healthcare Services
Validant, a transatlantic quality, compliance and regulatory consulting group backed by GHO Capital, has acquired DataRevive, a regulatory strategy and consulting firm focused on novel therapeutics and biologics. The deal expands Validant's capabilities in life‑science regulatory consulting and adds a Washington, D.C. location to its existing footprint in San Francisco, Research Triangle Park and Cork, Ireland.
-
Coker Acquires Healthcare Cost Solutions
June 25, 2025
Healthcare Services
Coker, a Trinity Hunt Partners-backed healthcare advisory firm, has acquired Healthcare Cost Solutions (HCS), a California-based leader in coding audit and health information management services. The acquisition brings HCS's proprietary HART technology and coding compliance capabilities into Coker's expanding healthcare advisory platform as an add-on to broaden compliance and coding audit services for hospitals, health systems and physician groups.
-
Validant Acquires Greenleaf Health
April 23, 2021
Healthcare Services
Validant, a PE-backed global quality, compliance and regulatory consulting group, has acquired Greenleaf Health, a Washington, D.C.-based FDA regulatory consulting firm. Concurrent with the acquisition, Greenleaf founder Patrick Ronan was named CEO of Validant as the combined group expands its regulatory and quality capabilities supported by GHO Capital.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.